This past weekend, 17 of the leading researchers in the diabetes community traveled to San Diego, CA, to speak at TEDxDelMar, an exciting day-long conference focused on the latest breakthroughs and continuing challenges in the search for a cure. Although the cure was the main focus of the day, TEDxDelMar also featured discussions on living well with diabetes (with talks including Dr. Steve Edelman and Dr. Bill Polonsky) and the future of diabetes technology (with…Read more »
Lots of organizations are working on new ways to accomplish islet cell transplantation in which the immune system does not kill off the transplanted cells. If they could do that, we’d likely have a cure for diabetes. But it ain’t easy, especially because we’re talking about transplanting into people whose immune systems are in mega-attack mode to begin with (type 1 diabetics).
The Diabetes Research Institute (DRI) in Florida is currently working on this challenge…
Dan Hurley, award-winning journalist and author of the new book Diabetes Rising is turning out to have some controversial views. He certainly thinks about Type 1 diabetes — which he’s lived with himself for 34 years — in different terms than I do; he’s very focused on causes and prevention, while I’m just trying to work out how to live with this thing. When I approached Dan to write a piece here at the ‘Mine…Read more »
Living in the United States, we are often stuck in a bubble of US-centric news. This is true for diabetes as much as any other topic. But as World Diabetes Day attests to, diabetes is hardly just an American thing. In reality, there’s much more going on in the global diabetes research arena than you might think (since our media announcements are pretty much limited to, err, Boston, Miami and the Bay Area). So today,…Read more »
Get ready for a post with a lot of fancy science words. It can’t be helped. That’s because if you’re going to use pig cells to potentially cure type 1 diabetes, you need a LOT of science.
MicroIslet Inc. is a biotech firm based in San Diego, CA, that ironically declared bankruptcy last year, but is pulling itself up by the bootstraps to realize its transplantation therapy dream. It is now gearing up to launch…